… doses of heparin/LMWH in COVID-19 patients. In addition, identification of specific heparin-…
potential for COVID-19 patients, and patients suffering from other inflammatory diseases. …

… Finally, we discuss potential risks associated with the implementation of heparin for the
treatment of SARS-CoV-2, including but not limited to bleeding and immune-mediated …

… of COVID-19. Tang et al reported that heparin (particularly low molecular weight heparin) …
In Japan, anticoagulants used for DIC include heparin as well as antithrombin concentrates, …

… In this review, we comprehensively discussed the potential of heparin therapy for COVID-19.
With multi-functions including its anticoagulant, anti-inflammatory and antiviral activities, …

… These findings come against several preliminary reports suggesting the potential role of
heparin in reducing mortality [5]. Meanwhile, regression models (Fig. 1b) revealed no significant …

… for the importance of heparin usage in COVID-19.[27] In fact, the antiviral activity of heparin
may … sprays are undergoing clinical trials to evaluate their potential to mitigate SARS-CoV-2 …

… of LMWH as a potential therapeutic drug for the treatment of COVID-19, paving the way …
heparin/LMWH for the treatment of COVID-19, our study signifies an additional activity of heparin …

… One potential advantage of using CS-E 19-mer is that the oligosaccharide does not cross …
and COVID-19 is under way. We believe that the beneficial effects of unfractionated heparin …

… , in addition to its anticoagulant properties, has anti-inflammatory and potential anti… heparin
compared with usual care using lower doses of heparin in hospitalized patients with Covid-19…

… and a potential antiviral effect. We hypothesized that low-molecular-weight heparin may
attenuate cytokine storm in COVID-19 … In this paper, we review potential mechanisms involved in …